These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 14991900

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
    Tang Y, Kesavan P, Nakada MT, Yan L.
    Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
    [Abstract] [Full Text] [Related]

  • 3. Matrix-metalloproteinases in Hodgkin lymphoma.
    Thorns C, Bernd HW, Hatton D, Merz H, Feller AC, Lange K.
    Anticancer Res; 2003 Feb; 23(2B):1555-8. PubMed ID: 12820423
    [Abstract] [Full Text] [Related]

  • 4. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
    Zhu P, Ding J, Zhou J, Dong WJ, Fan CM, Chen ZN.
    Arthritis Res Ther; 2005 Feb; 7(5):R1023-33. PubMed ID: 16207318
    [Abstract] [Full Text] [Related]

  • 5. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
    van den Oord JJ, Paemen L, Opdenakker G, de Wolf-Peeters C.
    Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
    [Abstract] [Full Text] [Related]

  • 6. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R, Bültmann A, Ungerer M, Joghetaei N, Bülbül O, Thieme S, Chavakis T, Toole BP, Gawaz M, Schömig A, May AE.
    Circulation; 2006 Feb 14; 113(6):834-41. PubMed ID: 16461815
    [Abstract] [Full Text] [Related]

  • 7. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
    Dong W, Xiang J, Li C, Cao Z, Huang Z.
    J Periodontal Res; 2009 Feb 14; 44(1):125-32. PubMed ID: 19515022
    [Abstract] [Full Text] [Related]

  • 8. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG, Nowak RA.
    Am J Reprod Immunol; 2006 Sep 14; 56(3):201-14. PubMed ID: 16911716
    [Abstract] [Full Text] [Related]

  • 9. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
    Nabeshima K, Iwasaki H, Nishio J, Koga K, Shishime M, Kikuchi M.
    Anticancer Res; 2006 Sep 14; 26(2B):1359-67. PubMed ID: 16619545
    [Abstract] [Full Text] [Related]

  • 10. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts.
    Li R, Huang L, Guo H, Toole BP.
    J Cell Physiol; 2001 Mar 14; 186(3):371-9. PubMed ID: 11169976
    [Abstract] [Full Text] [Related]

  • 11. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions.
    Sun J, Hemler ME.
    Cancer Res; 2001 Mar 01; 61(5):2276-81. PubMed ID: 11280798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
    Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S.
    Biochimie; 2005 Mar 01; 87(3-4):361-8. PubMed ID: 15781323
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts.
    Sato T, Ota T, Watanabe M, Imada K, Nomizu M, Ito A.
    Gynecol Oncol; 2009 Aug 01; 114(2):337-42. PubMed ID: 19427027
    [Abstract] [Full Text] [Related]

  • 16. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
    Erdem NF, Carlson ER, Gerard DA, Ichiki AT.
    J Oral Maxillofac Surg; 2007 Sep 01; 65(9):1725-33. PubMed ID: 17719389
    [Abstract] [Full Text] [Related]

  • 17. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
    Chen L, Nakai M, Belton RJ, Nowak RA.
    Reproduction; 2007 Feb 01; 133(2):405-14. PubMed ID: 17307908
    [Abstract] [Full Text] [Related]

  • 18. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N, Zafrakas K, Assmann V, Egen C, Riethdorf L, Riethdorf S, Berger J, Ebel S, Jänicke F, Sauter G, Pantel K.
    Clin Cancer Res; 2004 May 15; 10(10):3422-8. PubMed ID: 15161697
    [Abstract] [Full Text] [Related]

  • 19. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.
    Guo H, Li R, Zucker S, Toole BP.
    Cancer Res; 2000 Feb 15; 60(4):888-91. PubMed ID: 10706100
    [Abstract] [Full Text] [Related]

  • 20. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD, He HC, Bi XC, Qin WJ, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Zhu G, Chen ZN, Zhong WD.
    J Surg Res; 2010 May 15; 160(2):260-7. PubMed ID: 19286191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.